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Abstract 
 
Water hyssop and “Brahmi” are two words used for Bacopa monneri in the traditional 
system of medicine. Traditionally, it was used as a brain tonic to enhance learning & 
memory, and to provide relief in anxiety or epileptic disorders. The plant has also been used 
as a cardiac tonic, digestive aid and to improve respiratory function in cases of 
bronchoconstriction.
 
Brahmi contains bacoside A & B, Brahmin as main alkaloid and others 
are nicotine, herpestine. Bacoside A, B are the major constituents present in Brahmi plant in 
the form of saponins other than this D- mannitol, hersaponin and potassium salts are also 
present.  In this review we discuss primarily on pharmacological properties, chemical 
constituents and scientific researches supporting the  not only traditional use of Ayurvedic 
claims regarding Brahmi plant but also other physiological conditions such as anti-
inflammatory, cardio tonic and other pharmacological effects of BM preparations/extracts. 
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Introduction  
Brahmi is derived from word 
“Brahma” the mythical creator of Hindu 
pantheon and brain is the centre of creative 
activity in human body, those compounds 
that improve brain health is called Brahmi. 
The first clear reference of Brahmi 
regarding augmentation of memory is 
found in Charak Samhita (1), where 
Brahmi is prescribed as a cure for mental 
disorder (retardation) leading to insanity. 
The aetiology of the mental disorder 
according to Charak is a combination of 
anxiety, weak intellect and lack of 
concentration. Another authentic Ayurveda 
treatise i.e. Susruta Samhita has described 
Brahmi as efficacious in loss of intellect 
and memory. It is classified as a “Medhya 
Rasayan” drugs used to improve memory 
and intellect (Medhya), has been used by 
Ayurvedic medical practitioners in India 
for almost 3000 years. Plants have been 
used in different formulations which are 
used in various disorders in traditional 
system of medicine and researchers 
supports that some natural compound 
present in it act as Nootropic activity (2). 
Active ingredients of Brahmi known as 
bacosides, which are responsible for 
improving memory, related disorders, and 
enhance efficiency of transmission of 
nerve impulse there by strengthening 
memory and cognition (3).The increasing 
demand of herbal medicine in recent years 
is observed which may be due to lesser 
side effect in comparison to recent 
synthetics drugs. To overcome this 
solution pharmaceutical industry develops 
in vitro system for production of medicinal 
plants and their extracts (4). 
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Description of Plants 
Bacopa monneri, a member of the 
Scrophulariaceae family, is a small, 
creeping herb with numerous branches, 
small oblong leaves, and light purple 
flowers. In India and the tropics, it grows 
naturally in wet soil, shallow water, and 
marshes. It is also found in Nepal, 
Srilanka, China, Taiwan, Vietnam, Florida 
and Southern states of USA. It is widely 
distributed in warmer parts of Asia, 
Australia, America and India commonly 
known as Brahmi or Indian water hyssop 
has been investigated (5)
. 
The herb can be 
found at elevations from sea level to 
altitudes of 4,400 feet, and is easily 
cultivated if adequate water is available. 
Flowers and fruit appear in summer and 
the entire plant is used for medicinal 
purpose (6). 
 
Ethnopharmacology:  
It is astringent, bitter, having 
cooling properties and is reported to 
improve the intellect. It is widely used for 
the treatment of asthma, hoarseness, 
dermatitis, anaemia, diabetes, cardiac 
disorders, insanity, and epilepsy. It is also 
used in boils as blood purifier, used in 
cataract complaints.  Whole plant is used 
for medicinal purpose like juice of the 
leaves for relief in bronchitis and diarrhoea 
given to children, paste of the leaves is 
used as a remedy for rheumatism, leaves 
and tender stalks are reported to be eaten 
in the west Bengal and decoction of leaves 
is used in cough disorders. It is also 
observed that it is safe cardiac tonic, gives 
relief to patients from anxiety neurosis if 
given with ginger juice, sugar and bark 
extracts of Moringa oleifera. It was 
reported as a potent antioxidant and 
bronco-vasodilator.  
 
Phytochemistry:  
In view of the importance of this 
plant in the indigenous system of 
medicine, systematic chemical 
examinations of the plant have been 
carried out by several groups of 
researchers. Detailed investigations were 
first documented in 1931, when Bose and 
Bose reported the isolation of the alkaloid 
"Brahmin" from Bacopa monneri (BM) 
and other alkaloids like nicotine and 
herpestine have also been reported later 
(7). It was found highly toxic, when 
administered at a dose of 0.5 mg/kg body 
weight of cat, it produces a fall in the 
blood pressure. In therapeutic doses it 
action resembles with action of strychnine 
chemical. The isolation of D-mannitol, 
saponins, hersaponin and potassium salts 
by Sastri provided further details of the 
chemical components of BM (8). The 
major chemical entity shown to be 
responsible for the memory-facilitating 
action of BM, Bacoside A, was assigned as 
3-((alpha)-L-arabinopyranosyl)-O-(beta)-
D-glucopyranoside-10, 20-dihydroxy-16-
keto-dammar-24-ene (9). It usually co-
occurs with Bacoside B, the latter differ to 
each other only in optical (10).  Bacosides 
A and B possess haemolytic activity. On 
acid hydrolysis, Bacosides yield a mixture 
of aglycones, bacogenin (11), and two 
genuine sapogenins, jujubogenin and 
pseudojujubogenin (12). In addition, same 
authors isolated three new saponins from 
BM, designated as bacopasides III, IV and 
V (13). Moreover, three new 
phenylethnoid glycosides, viz. 
monnerisides I-III along with the known 
analogue plantainoside B have been 
isolated from the glycoside fraction of BM 
(14). Analysis of the leaves and stalks 
exposed, moisture 88.4; protein 2.1: fat 
0.6; carbohydrates 5.9; crude fibre 1.05;  
ash 1.9 g / 100gm, calcium 202.0;  
phosphorus 16.0; iron 7.8; ascorbic acid 
63.0; nicotinic acid 0.3 mg /100 g; and 
energy 38 cal / 100 g. The leaves contain a 
sterol C 26 H 46 O .H2O, m p 76 
0) 
(15).      
    
Pharmacological Properties:  
Anti Asthmatic Activity:  
BM extract possessed 
relaxant properties in tracheal muscle of 
rabbit and guinea-pigs with a partial 
contribution by (beta)-adrenoreceptor and 
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prostaglandins (16). It also 
produced bronco dilation in anaesthetized 
rats (17)
 
supported the traditional use of 
this plant in for various respiratory 
ailments (18). Bronchodilator property of 
extract may be reflected by antagonism of 
carbachol-induced effects 
on inspiratory and expiratory pressures. 
Extract exhibited a dual action on 
bronchoconstriction induced by carbachol. 
At low doses (25 and 37 mg/kg), 
predominantly inhibited inspiratory 
pressure, but at a high dose (50 mg/kg) 
inhibited only expiratory pressure. This 
property of the plant extract implies that 
more than one mechanism of action may 
be responsible for bronco-dilation. Some 
of the possible mechanisms include (beta)-
adrenoreceptor activation, muscarinic 
receptor antagonism, prostaglandin release 
or interference with calcium mobilization. 
A more recent study by the same authors 
demonstrates the calcium antagonistic 
activity is present in ethanol extract of BM 
(19). In addition, it has been reported that 
BM methanolic extract exhibited a 
potent mast cell stabilizer, indicating the 
potential usefulness of BM leaves in 
allergic conditions (20).   
             
Anti cancer activity: 
Pre treatment with BM 
significantly reduced the acute stress (AS)-
induced increase in the ulcer index, 
adrenal gland weight, plasma glucose, 
aspartate aminotransferase (AST), and 
creatine kinase (CK) (21) in cancerous 
patients. This was due to presence of 
Bacosides present in BM, which have 
anticancer activity. Methanolic extract 
exhibited potent mast cell stabilizer (22) 
activity. Bacopa monneri is a known hyper 
accumulator of cadmium, chromium, lead 
& mercury and used for phytoremedy (23). 
                                                
Anticonvulsive 
Bacopa has been indicated as a 
remedy for epilepsy in Ayurvedic 
medicine and animal research showed 
anticonvulsant activity present in it, only at 
high doses over extended periods of time. 
It have been also reported that crude water 
extract of BM controls epilepsy in 
experimental animals (24). The naturally it 
exhibited sedative effect and significantly 
prolonged hypnotic action of 
phenobarbitone. Those substances which 
stimulate GABA are known to possess 
anticonvulsant, pain relieving and sedative 
effects (26). It suggests the involvement of 
GABA-ergic system in mediation of 
central nervous system (25). BM was 
evaluated alone and in combination 
with phenytoin (PHT) for its effect on PA 
task, maximal electroshock seizures and 
locomotors activity in mice (27). Both 
acquisition and retention of memory 
showed improvement without affecting 
PHT anti convulsive activity. Further 
investigations using BM alone or in 
combination with other antiepileptic drugs 
are warranted to explore the full potential 
of BM in epilepsy. 
 
Antidepressant:  
Methanolic extract of BM possess 
potential antidepressant activity in rodent. 
When given in the dose of 20 and 40 
mg/kg, orally for 5 days, the extract was 
found to have significant antidepressant 
activity in forced swim and learned 
helplessness models of depression and was 
comparable to that of imipramine (28). 
 
Anti inflammatory: 
Bacopa monneri has the ability to 
inhibit inflammation through modulation 
of pro-inflammatory mediator release (29) 
i.e. it possesses significant anti-
inflammatory activity that may well be 
relevant to its effectiveness in the healing 
of various inflammatory conditions in 
traditional medicine (30). It also 
significantly inhibited 5-lipoxygenase (5-
LOX), 15-LOX and cyclooxygenase-2 
(COX-2) activities (31). This activity may 
be due to presence of the triterpenoids and 
bacosides in it.  
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Anti nociceptive activity: 
Aqueous extract of Bacopa 
monneri (AEBM) exhibits analgesic 
activity through multiple pain pathways 
(32) i.e. involvement of β1-adrenergic, α2 -
adrenergic receptors and 5-HT receptors in 
analgesic activity. It was also observe that 
when AEBM was given in combination 
with naloxone did not increase the latency 
for analgesic effect, which indicates 
involvement of opioid receptors in 
analgesic activity.      
 
Antioxidant activity:  
Alcoholic and hexane extract of 
BM have antioxidant properties (33)
 
by 
inhibiting lipid peroxidation. A more 
recent study explored antioxidant effect of 
BM by other mechanism like inhibition of 
superoxide dismutase 
(SOD), catalase (CAT) and glutathione 
peroxidise (GPX) activities (34). It was 
also observed that the hydro alcoholic 
extract of the whole BM plant exhibited an 
inhibitory effect on superoxide released 
from polymorphonuclear cells in nitro 
blue assay (35). Sumathy et al. (2001) 
investigated hepato protective activity of 
alcoholic extract BM on morphine-treated 
rats (36). It may be due to decreased brain 
mitochondrial enzyme activity in rats (37). 
Methanolic  extract BM is able to directly 
inhibit the superoxide anion formation in a 
dose-dependent manner due to this  it 
reduces concentrations of nitric oxide 
(NO), generated (enzymatic and non-
enzymatic) by activated astrocytes, might 
be involved in a variety of 
neurodegenerative diseases, such as AD, 
ischemia and epilepsy(38, 39).  
        
Anti stress Activity: 
Standardized extract of BM 
possesses an adaptogenic activity.  Pre 
treatment with low dose of BM extract 
significantly reversed changes in ulcer 
index and plasma AST only, whereas the 
pre treatment with higher dose 
significantly reversed changes in ulcer 
index, adrenal gland weight, CK, and AST 
(40). 
 
Anti Spasmodic Activity: 
BM extract have 
spasmolytic activity in smooth muscles 
due to inhibition of calcium influx via both 
voltage and receptor-operated calcium 
channels of the cell membrane. (41) 
However, the absence of any modification 
of either nor-adrenaline or caffeine-
induced contractions in the presence of 
BM extract suggests that this natural 
compound has no detectable effect on 
mobilization of intracellular calcium.   
 
Anxiolytic effect: 
The higher doses of BM extract 
produced significantly greater anxiolytic 
effects compared to LZP (42). However, 
BM has a distinct advantage over 
lorazepam (LZP) since it does not induce 
amnesia and has a memory-promoting 
action in animals and man (43, 44). These 
results was also observed by Shanker and 
Singh and reported that BM extract 
possessed an anxiolytic effect (45).  
 
Cardiovascular activity: 
Ethanolic extract of BM, shown 
cardiac depressive activity on left 
ventricular contractility, heart rate and 
coronary flow in isolated rabbit heart (46). 
It also demonstrated that protective effect 
of BM on pulmonary artery and aorta (47). 
 
Gastroprotective activity: 
The anti-ulcer and ulcer-healing 
activities of the Bacopa monneri extract 
may be due to its effects on various 
mucosal offensive and defensive factors 
(48). It also have beneficial role in 
intestinal spasm such as irritable bowel 
syndrome (49).  It may be due to 
spasmolytic activity on intestinal smooth 
muscle, via inhibition of calcium influx 
across cell membrane channels. Fresh BM 
juice (BMJ) and BM extract has been 
reported to have significant anti 
ulcerogenic activity (50, 51, 52). Ulcer 
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protective effect of BMJ may be due to its 
effect on mucosal defensive factors such as 
enhanced mucin secretion, mucosal 
glycoprotein and decreased cell shedding, 
rather than on offensive factors such as 
acid and pepsin.  
 
Hepatoprotective activity: 
It was found that pre treatment with 
BM extract has shown to possess a 
significant protective effect against 
morphine-induced liver and kidney 
functions in terms of serum glutamate 
oxaloacetate transaminase, serum 
glutamate pyruvate transaminase, alkaline 
phosphatase, lactate dehydrogenases and 
gamma-glutamyl transferase activities and 
urea, creatinine and uric acid level 
respectively (53). Pre treatment of 
Bacoside A also prevents the elevation of 
LPO (Lipid Peroxidise) and activity of 
serum marker enzymes and maintains the 
antioxidant system and thus protects the 
rats from Diethyl nitrosamine-induced 
hepatic toxicity (54).  
 
Learning and memory: 
Plant extracts and isolated 
Bacosides have been extensively 
investigated in several laboratories for 
their neuro pharmacological effects and 
number of reports are available confirming 
their Nootropic action. Preliminary studies 
established that treatment with plant (55) 
or alcoholic extract of BM plant (56) 
enhanced learning ability in rats. 
Subsequent studies indicated that the 
cognition-facilitating effect was due to 
presence of Bacosides A and B, in ethanol 
extract (43). These active principles, apart 
from facilitating learning and memory in 
normal rats, inhibited the amnesic effects 
of scopolamine, electroshock and immobili
zation stress (44). The mechanism of these 
pharmacological actions remains 
conjectural. It has been suggested that 
bacosides induce membrane 
dephosphorylation, with concomitant 
increase in protein and RNA turnover in 
specific brain areas (57). BM has been 
shown to enhance protein kinase activity in 
hippocampus which could also contribute 
to its nootropic action (58). Administration 
of BM for two weeks, also reversed the 
depletion of acetylcholine, the reduction in 
acetyl cholinesterase activity and the 
decrease in muscarinic cholinergic 
receptor binding in the frontal cortex and 
hippocampus, induced by neurotoxin, 
colchicines (59). It has been suggested that 
the behavioural effects of cholinergic 
degeneration can be alleviated by a 
reduction in noradrenergic function (60). 
BM is known to lower nor epinephrine and 
increase 5-hydroxytryptamine levels in the 
hippocampus, hypothalamus and cerebral 
cortex (58), thus BM indirectly, modify 
Ach concentrations.  
 
Dosage: 
Traditional daily doses of Bacopa 
was 5- 10 gm of non-standardized powder, 
8-16 ml of infusion, and 30 ml daily of 
syrup (Brahmi). Dosages of 1:2 fluid 
extract are 5-12 ml per day for adults and 
2.5-6 ml per day for children ages 6-12 
years. For Bacopa extracts standardized to 
20-percent Bacosides A and B, dosage is 
200-400 mg daily in divided doses for 
adults, and for children, 100-200 mg daily 
in divided doses. 
 
Conclusion: 
Bacopa monneri, traditional 
Ayurvedic medicinal plant has been used 
for centuries as a memory-enhancing, anti-
inflammatory, analgesic, antipyretic, 
sedative, and antiepileptic agent. More 
recently, preclinical studies and clinical 
studies supported the cognitive enhancing 
effects with various extracts of BM, but 
the exact mechanism of its actions is still 
uncertain, as its multiple active 
constituents make its pharmacology 
complex. It has been suggested that BM, 
like Ginkgo biloba, exhibits protective and 
cognitive enhancing effects, to modulate 
the cholinergic system and to contrast 
oxidative stress. . 
 
Published online in http://ijam.co.in 
ISSN:  0976-5921 
Yadav Kapil Deo et.al., Critical review on  pharmacological properties of Brahmi 
 
97 
References:   
1. T Brahmanand. Charaka Chandrika 
Chikitsa Sthana: Varanasi, 
Chaukhambha Surbharti Publishers 
2004. 
2. Russo A, Borrelli F. Bacopa monneri, 
a reputed Nootropic plant: an 
overview.  Phytomedicine 2005; 
12:305-317. 
3. Anon, Bacopa monneri; Monograph 
Altern Med. Rev. 2004 9:79-85. 
4. Banerjee M, Shrivastava S. An 
improved protocol for in vitro 
multiplication of   Bacopa monneri (L):  
J. Microbio. Biotechnol, Springer 
Netherlands, 2008; 24: 1355-1359. 
5. Kapoor LD.  CRC Handbook of 
Ayurvedic medicinal Plants: Florida 
CRC Press, Boca Raton. 1990.  
6. Bone K. Clinical Applications of 
Ayurvedic and Chinese Herbs: 
Monographs for the Western Herbal  
Practitioner. Warwick, Queensland: 
Phytotherapy Press; 1996. 
7. Chopra RN, Nayar L, Chopra IC. 
Glossary of Indian Medicinal Plants. 
vol. 32. Council of Scientific and 
Industrial Research, New Delhi. 1956. 
8. Shastri MS, Dhalla NS, Malhotra CL. 
Chemical investigation of Herpestis 
monneri Linn (Brahmi). Indian J. 
Pharmacol. 1959; 21:303-304. 
9. Chatterji N, Rastogi RP, Dhar ML. 
Chemical examination of Bacopa 
monneri Wettst.: parti-isolation of 
chemical constituents. Indian J. Chem. 
1959; 3:24-29. 
10. Rastogi RP. Compendium of Indian 
Medicinal Plants. CSIR, New Delhi, 
1990:1: pp. 118-122. 
11. Chandel RS, Kulshreshtha DK, 
Rastogi RP. Bacogenin (A.sub.3): a 
new sapogenin from Bacopa monneri. 
Phytochemistry 1977;16:141-143. 
12. Rastogi S, Pal R, Kulshreshtha DK. 
Bacoside A3-a triterpenoid saponin 
from Bacopa monneri. Phytochemistry 
1994; 36:133-137.  
13. Chakravarty AK, Garai S, Masuda K, 
Nakane T, Kawahara N. Bacopasides  
III-V: three new triterpenoid 
glycosides from Bacopa monneri. 
Chem. Pharm. Bull. 2003; 51: 215-
217.  
14. Chakravarty AK, Sarkar T, Nakane T, 
Kawahara N, Masuda K. New 
phenylethanoid glycosides from 
Bacopa monneri. Chem. Pharm. Bull. 
2002; 50, 1616-1618.                   
15. htpp// 
herbalnet.org/wholherb/bacopa_mon.as
ps 
16. Dar A, Channa S. Bronchodilatatory 
and cardiovascular effects of an 
ethanol extract of Bacopa monniera in 
anaesthetized rats. Phytomedicine 
1997b; 4:319-323. 
17. Nadkarni KM. The Indian Materia 
Medica. Columbia, MO: South Asia 
Books; 1988:624-625. 
18. Dar A, Channa S. Calcium antagonistic 
activity of Bacopa monniera on 
vascular and intestinal smooth muscles 
of rabbit and guinea-pig. J. 
Ethnopharmacol. 1999;66:167-174. 
19. Sharma R, Chaturvedi C, Tewari PV. 
Efficacy of Bacopa monnieri in 
revitalizing intellectual functions in 
children. J Res Edu Indian Med 1987; 
Jan-June: 1-12. 
20. Negi KS, et al. Clinical evaluation of 
memory enhancing  properties of 
Memory Plus in children with attention 
deficit hyperactivity disorder. Ind. J 
Psychiatry 2000; 42: Supplement. 
(Abstract)  
21. Rai D, Bhatia G, Palit G and Pal R. 
Adaptogenic effect of Bacopa monneri 
(Brahmi), Pharmacol. Biochem. 
Behav, 2003;75: 823-830.  
22. Samiulla DS. Prashanth D, Amit A. 
Mast cell stabilising activity of Bacopa 
monnieri,   Fitoterapia, 2001; 72:284-
285. 
23. Tripathi YB, Chaurasia S, Tripathi E 
and Upadhyay A. Bacopa monniera 
Linn. as an  antioxidant: mechanism of 
Published online in http://ijam.co.in 
ISSN:  0976-5921 
International Journal of Ayurvedic Medicine, 2013, 4(2), 92-99 
 
98 
action, Indian J. Exp. Biol, 1996; 34: 
523-526. 
24. Shanmugasundaram ER, Akbar GK, 
Shanmugasundaram KR. 
Brahmighritham, an Ayurvedic herbal 
formula for the control of epilepsy. J. 
Ethnopharmacol. 1991; 33: 269-276. 
25. Singh HK, Shanker G, Patnaik GK. 
Neuropharmacological and anti-stress 
effects of bacosides: a memory 
enhancer: Indian J. Pharmacol. 1996; 
28: 47. 
26. Shanker G, Singh HK. Anxiolytic 
profile of standardized Brahmi extract: 
Indian  J. Pharmacol. 2000; 32:152. 
27. Vohora D, Pal SN, Pillai KK. 
Protection from phenytoin-induced 
cognitive deficit by Bacopa monneri, a 
reputed nootropic plant: J. 
Ethnopharmacol. 2000; 71: 383-390. 
28. Sairam K, Dorababu M, Goel RK, 
Bhattacharya SK. Antidepressant 
activity of standardized extract of 
Bacopa monniera in experimental 
models of depression in rats:  
Phytomedicine 2002; 9:207-211 
29. Viji V, Helen A. Inhibition of pro-
inflammatory mediators: role of 
Bacopa monniera   (L.) Wettst, 
Inflammo J. Ethnopharmacol. 2010. 
30. Channa S, Dar A, Anjum S and 
Yaqoob M. Anti-inflammatory activity 
of Bacopa monniera in rodents: J. 
Ethnopharmacol., 2006; 104(1-2): 286-
289. 
31. Viji V and Helen A. Inhibition of 
lipoxygenases and cyclooxygenase-2 
enzymes by  extracts isolated from 
Bacopa monniera (L.) Wettst, J. 
Ethnopharmacol., 2008; 23, 118(2): 
305-311. 
32. Manju B,  Jagtap AG. Exploring the 
possible mechanisms of action behind 
the antinociceptive activity of Bacopa 
monniera  Int J Ayurveda 
Res. 2011; 2: 2–7 
33. Tripathi YB, Chaurasia S, Tripathi E, 
Upadhyay A, Dubey GP. Bacopa  
monniera Linn. as an antioxidant: 
mechanism of action: Indian J. Exp. 
Biol. 1996; 34:523-526. 
34. Bhattacharya SK, Bhattacharya A, 
Kumar A, Ghosal S. Antioxidant 
activity of Bacopa monniera in rat 
frontal cortex, striatum and 
hippocampus: Phytother. Res. 
2000;14:174-179. 
35. Pawar R, Gopalakrishnan C, Bhutani 
KK. Dammarane triterpene saponin 
from    Bacopa monniera as the 
superoxide inhibitor in 
polymorphonuclear cells: Planta Med. 
2001; 67:752-754. 
36. Sumathi T, Nayeem M, Balakrishna K. 
Alcoholic extract of Bacopa monneri 
reduces the in vitro effects of morphine 
withdrawal in guineapig J 
Ethnopharmacol 2002; 82:75-81 
37. Sumathy T, Govindasamy S, 
Balakrishna K, Veluchamy G. 
Protective role of Bacopa monniera on 
morphine-induced brain mitochondrial 
enzyme activity in rats: Fitoterapia 
2002; 73:381-385. 
38. Colasanti M, Suzuki H. The dual 
personality of NO. TPS 2000; 21:249-
252. 
39. Russo A et al.. Nitric oxide-related 
toxicity in cultured astrocytes: effect of 
Bacopa monniera: 2003b;  Life Sci. 
73:1517-1526. 
40. D, Bhatia G, Palit G, Pal R. 
Adaptogenic effect of Bacopa 
monniera (Brahmi): Pharmacol 
Biochem. Behav. 2003;75: 823-830. 
41. Ganguly D K, Malhotra CL, Indian J. 
Med. Res.,1967, 55:473 
42. Bhattacharya SK, Ghosal S. Anxiolytic 
activity of a standardized extract of 
Bacopa monneri; an experimental 
study. Phytomedicine 1998; 5:77-82. 
43. Singh HK, et al. Drugs affecting 
learning and memory. In:. (Eds.), 
Lectures in Neurobiology Wiley 
Eastern, 1992; 1: pp. 189-207. 
44. Dhawan BN, Singh HK. Pharmacology 
of ayurvedic nootropic Bacopa 
Published online in http://ijam.co.in 
ISSN:  0976-5921 
Yadav Kapil Deo et.al., Critical review on  pharmacological properties of Brahmi 
 
99 
monneri, Abstr. No. NR 59. Int. Conv. 
Biol. Psychiat1996 
45. Shanker G, Singh HK. Anxiolytic 
profile of standardized Brahmi extract: 
Indian J. Pharmacol. 2000; 32:152. 
46. Rashid S, Lodhi F, Ahmad M and 
Usmanghani K. Cardiovascular effects 
of Bacopa monnieri (L.) pennel extract 
in rabbits: Pak. J. Pharm. Sci., 1990; 
3(2): 57-62. 
47. Dar A, Channa S. Relaxant effect of 
ethanol extract of Bacopa monneri on 
trachea, pulmonary artery and aorta 
from rabbit and guinea-pig: Phytother. 
Res., 1999; 11: 323-325. 
48. Dorababu M, Prabha T, Priyambada S, 
Agrawal VK. Effect of Bacopa 
monneri and      Azadirachta indica on 
gastric ulceration and healing in 
experimental NIDDM rats: Indian  J. 
Exp. Biol., 2004; 42:389. 
49. Dar A, Channa S. Calcium antagonistic 
activity of Bacopa monneri on vascular 
and intestinal smooth muscles of rabbit 
and guinea-pig: J. Ethnopharmacol, 
1999; 66: 167- 174. 
50. Goel RK, Sairam K, Babu MD and 
Tavares IA. In vitro evaluation of 
Bacopa monneri on anti-Helicobacter 
pylori activity and accumulation of 
prostaglandins:  Phytomed., 2003; 10: 
523-527.  
51. Rao CHV, Sairam K, Goel RK. 
Experimental evaluation of Bacopa 
monniera on rat gastric ulceration and 
secretion: Indian J. Physiol. 
Pharmacol. 2000; 44:435-441.  
52. Sairam K, Rao CV, Babu MD, Goel 
RK. Prophylactic an curative effects of 
Bacopa monniera in gastric ulcer 
models. Phytomedicine 2001; 8:423-
430.  
53. Sumathi T, Niranjali,  Devaraj S. 
Effect of Bacopa monniera on liver and 
kidney toxicity in chronic use of 
opioids, Phytomed. 2009; 16(10): 897-
903.  
54. Janani P, Sivakumari K, Parthasarathy 
C. Hepatoprotective activity of 
bacoside A against N-
nitrosodiethylamine-induced liver 
toxicity in adult rats: Cell Biol. 
Toxicol., 2008; 25(5): 425-434 
55. Malhotra CL, Das PK. 
Pharmacological studies of Herpestis 
monneri Linn. (Brahmi): Indian J. 
Med. Res. 1959; 47:294-305 
56. Singh HK, Dhawan BN. Effect of 
Bacopa monniera extract on avoidance 
responses in rat. J. Ethnopharmacol. 
1982;5:205-214.  
57. Singh HK, Srimal RC, Srivastava AK, 
Garg NK, Dhanwan BN. 
Neuropsychopharmacological effects 
of Bacosides A and B. Proceedings of 
the Fourth Conference on 
Neurobiology Learning Memory, 
Abstract No. 79. Irvine 
California. 1990. 
58. Singh HK, Dhawan BN. 
Neuropsychopharmacological effects 
of the Ayurvedic  nootropic Bacopa 
monniera Linn (Brahmi): Indian J. 
Pharmachol. 1997; 29:359-365. 
59. Bhattacharya SK, Kumar A, Ghosal S. 
Effect of Bacopa monneri on animal 
models of Alzheimer's disease 
and perturbed central cholinergic 
markers of cognition in rats. In: Siva 
Sankar, D.V. (Ed.), Molecular Aspects 
of Asian Medicines. PJD Publications. 
1999.  
60. Sara SJ. Noradrenergic-cholinergic 
interaction: its possible role in memory 
dysfunction associated with senile 
dementia: Arch. Gerontol. Geriatr. 
1989; 1:99-108.  
61. Das A, Shanker G, Nath C, Pal R, 
Singh S, Singh, H. A comparative 
study in rodents of standardized 
extracts of Bacopa monneri and 
Ginkgo biloba. Pharmacol. Biochem. 
Behav. 2002; 73:893-900.  
 
***** 
